Anthropic CEO Dario Amodei announced that its AI system, Claude, has made a biomedical breakthrough by discovering a potential new gene editing mechanism. The AI found a previously unknown enzyme system in bacteriophages similar to CRISPR technology.

Anthropic CEO Dario Amodei predicts AI could help cure most diseases in five to 10 years as Claude discovers a potential new gene editing mechanism.

Anthropic says its AI Claude autonomously discovered a new CRISPR-like enzyme system, the first result from the company's new wet lab as it

Claude Opus 5.5 provide Fable 5.1-level performance on most work while Anthropic says typical workloads cost 40% less than Opus 5 with stronger agent safeguards

Anthropic has announced that its AI model, Claude, is significantly aiding in the development of building its successor.

Anthropic expands its Claude Marketplace with over 2,000 connectors. Valuation hitting $2 trillion by December at 67% YES.

The post Anthropic Claims Claude Uncovered a Brand-New Enzyme System Inside Virus DNA appeared first on Android Headlines.

US artificial intelligence startup Anthropic on Wednesday unveiled the first discovery from its molecular biology lab, a previously unknown enzyme system spotted by its Claude model and touted by the company as proof that AI can speed up basic research.